Schedule 13G ownership disclosure

CLEVELAND BIOLABS INC

Security class unavailable · CUSIP: 185860202

Event date: 2020-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-004035
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Jun 11, 2020
Reporting period
Jun 01, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub